It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
VigiAccess was launched by the World Health Organization (WHO) in 2015 to provide public access to information in VigiBase, the WHO global database of reported potential side effects of medicinal products. Side effects – known technically as adverse drug reactions (ADRs) and adverse events following immunization (AEFIs) – are reported by national pharmacovigilance centres or national drug regulatory authorities that are members of the WHO Programme for International Drug Monitoring (PIDM). WHO PIDM was created in 1968 to ensure the safer and more effective use of medicinal products.
originally posted by: AugustusMasonicus
a reply to: Chalcedony
Question on the younger than 12 category, how can there be data when there aren't any approved vaccines for that age group?
originally posted by: infolurker
Test subjects and idiots vax'ing their kids anyway.
originally posted by: infolurker
originally posted by: AugustusMasonicus
a reply to: Chalcedony
Question on the younger than 12 category, how can there be data when there aren't any approved vaccines for that age group?
Test subjects and idiots vax'ing their kids anyway.
We have plenty of idiots in this world.
originally posted by: AugustusMasonicus
originally posted by: infolurker
Test subjects and idiots vax'ing their kids anyway.
How are they going to 'vax their kids anyway'? It has to be administered by a healthcare professional.
originally posted by: AugustusMasonicus
a reply to: Chalcedony
Question on the younger than 12 category, how can there be data when there aren't any approved vaccines for that age group?
originally posted by: Chalcedony
Africa: 53,319
Americas: 747,048
Asia: 127,877
Europe: 1,040,145
Oceania: 60,911
originally posted by: AugustusMasonicus
a reply to: Chalcedony
Question on the younger than 12 category, how can there be data when there aren't any approved vaccines for that age group?
originally posted by: TrollMagnet
In Africa, you really think they care about the age recommended for the vaccine?
originally posted by: Chalcedony
I wondered that too. My best guess is maybe they had a reaction during a trial?
Blood and lymphatic system disorders (81120)
Cardiac disorders (95800)
Congenital, familial and genetic disorders (1053)
Ear and labyrinth disorders (66964)
Endocrine disorders (2589)
Eye disorders (74568)
Gastrointestinal disorders (426587)
General disorders and administration site conditions (1249946)
Hepatobiliary disorders (3872)
Immune system disorders (28019)
Infections and infestations (128575)
Injury, poisoning and procedural complications (94992)
Investigations (265566)
Metabolism and nutrition disorders (46546)
Musculoskeletal and connective tissue disorders (605783)
Neoplasms benign, malignant and unspecified (incl cysts and polyps) (2825)
Nervous system disorders (888607)
Pregnancy, puerperium and perinatal conditions (4155)
Product issues (3515)
Psychiatric disorders (96215)
Renal and urinary disorders (16025)
Reproductive system and breast disorders (70555)
Respiratory, thoracic and mediastinal disorders (213696)
Skin and subcutaneous tissue disorders (283487)
Social circumstances (13910)
Surgical and medical procedures (16924)
Vascular disorders (109965)
While many high-income nations, including the United States and most members of the European Union, now offer Covid vaccines for children 12 and older, a handful of countries have now authorized the shot for younger people. Meanwhile, severe vaccine inequality persists on a global level, with many developing nations continuing to struggle to provide first and second doses to high-risk groups -- with the very idea of getting shots to children still a pipe dream.
China - jab approved for children three and over
In June, China began to allow some children from three to 17 years old to be offered shots of a vaccine produced by drug-maker Sinovac, making it the first country to approve a jab for such a young age group.
In Chile, it has already been approved for use in children from six years old